Nachrichten zur Amgen Inc. Aktie

Nebulizer Patent Landscape Report 2024: Innovative Developments Fuel Market Growth

Dublin, Feb. 21, 2025 (GLOBE NEWSWIRE) -- The "Nebulizer Patent Landscape Report" report has been added to …

Amgen, Inc. (AMGN) Citis 2025 Virtual Oncology Leadership Summit Conference (Transcript)

…

This Company Just Initiated a Quarterly Dividend: Time to Buy?

Biotech giant Renegeron Pharmaceuticals (NASDAQ: REGN) reported its fourth-quarter and full-year 2024 earnings on Feb. 4. The companys results were…

Want Decades of Passive Income? Buy This ETF and Hold It Forever.

Who doesnt want passive income? Even Warren Buffett has extolled it, reportedly saying, "If you dont find a way to…

Amgen, Inc. (AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call Transcript

…

Genomic Data Analysis and Interpretation Market Research 2025-2033: Syngenta Group Leads, Followed by Amgen, Monsanto (Bayer), and Illumina

Dublin, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The "Genomic Data Analysis and Interpretation Market Opportunities and Strategies to…

Amgens EVP Jonathan Graham sells $7.34 million in stock By Investing.com

Amgens EVP Jonathan Graham sells $7.34 million in stock…

Investing $1,000 in These 3 Beaten-Down Stocks Could Be a Brilliant Move

Investing in stocks that arent performing well can be a good move, but only if there are good reasons to…

Better High-Yield Dividend Stock: Pfizer vs. Merck

Investors looking for ways to pump up their passive income streams might want to turn their heads toward the pharmaceutical…

3 Fabulous Dividend Stocks to Buy in February

February is the shortest month, but that doesnt mean income investors dont have much time to find great stocks. Three…

Amgen SVP Nancy Grygiel sells stock for $483,807 By Investing.com

Amgen SVP Nancy Grygiel sells stock for $483,807…

The Zacks Analyst Blog Highlights Amgen, CRISPR, Moderna, Sarepta and Vertex

Amgen, CRISPR, Moderna, Sarepta and Vertex are included in this Analyst Blog.…

GNW-News: Accumulus Synergy liefert das erste digital erstellte Dossier der Branche in fast zwei Dutzend Länder gleichzeitig

^BURLINGAME, Kalifornien, Feb. 05, 2025 (GLOBE NEWSWIRE) Accumulus Synergy(?Accumulus") hat in einem branchenweit einmaligen Moment den bahnbrechendenZulassungsantrag von Amgen…

Amgen schlägt die Erwartungen – Adipositas-Rückschlag belastet

Die Berichtssaison läuft weiter auf Hochtouren. Am Dienstag nach US-Börsenschluss hat auch der Biotech-Gigant Amgen die Zahlen für das abgelaufene…

Amgen (AMGN) Q4 2024 Earnings Call Transcript

AMGN earnings call for the period ending December 31, 2024.…

Compared to Estimates, Amgen (AMGN) Q4 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Amgen (AMGN) give a sense of how the business performed in the quarter…

Amgen (AMGN) Q4 Earnings and Revenues Surpass Estimates

Amgen (AMGN) delivered earnings and revenue surprises of 5.57% and 2.54%, respectively, for the quarter ended December 2024. Do the…

Amgen überrascht positiv mit Quartal und Prognose - Kurs dennoch unter Druck

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen blickt nach einem überraschend gut verlaufenen Quartal optimistisch in die Zukunft. 2025…

Amgen überrascht positiv mit Quartal und Prognose - Kurs dennoch unter Druck

THOUSAND OAKS (dpa-AFX) - Der US-Biotechkonzern Amgen blickt nach einem überraschend gut verlaufenen Quartal optimistisch…

Amgen profit beats estimates, next MariTide studies start by mid-year

Amgen posted a higher quarterly profit on Tuesday, driven by an 11% rise in product sales, and said late-stage studies…

Amgen profit beats estimates, next MariTide studies start by mid-year By Reuters

Amgen profit beats estimates, next MariTide studies start by mid-year…

These Were the 5 Top-Performing Stocks in the Dow Jones Industrial Average in January 2025

The Dow Jones Industrial Average got off to a solid start this year. The widely reported index, consisting of 30…

The Zacks Analyst Blog Highlights Merck, Pfizer, Eli Lilly, Amgen and Bristol Myers Squibb

Merck, Pfizer, Eli Lilly, Amgen and Bristol Myers Squibb are included in this Analyst Blog.…

EUROPÄISCHE KOMMISSION GENEHMIGT BLINCYTO® BEI PHILADELPHIA-CHROMOSOM-NEGATIVER CD19-POSITIVER B-ZELL-VORLÄUFER-AKUTER LYMPHOBLASTISCHER LEUKÄMIE IN DER KONSOLIDIERUNGSPHASE

Amgen: Thousand Oaks, Kalifornien. (ots/PRNewswire) - BLINCYTO wurde zusätzlich zu einer mehrphasigen konsolidierenden Chemotherapie eingesetzt und senkte das Sterberisiko im…

These Were the 5 Worst-Performing Stocks in the Dow Jones Industrial Average in 2024

The Dow Jones Industrial Average (DJIA) is a group of 30 U.S. industry leaders. Its often looked at as a…

Can the 8 Worst-Performing Dow Jones Stocks in 2024 Beat the S&P 500 in 2025?

2024 was an excellent year for the major stock market indexes. But the Dow Jones Industrial Average (DJINDICES: ^DJI) had…

Amgen: Likely To Be Rangebound (Rating Downgrade)

…

Amgens Lumakras Gets FDA Nod for Expanded Use in Colorectal Cancer

The FDA approves Amgens Lumakras in combination with Vectibix for treating previously treated adults with KRAS G12C-mutated metastatic colorectal cancer.…

Amgen Aktie: Starkes Wachstum sichert Zukunft

Die Amgen Aktie zeigt sich zum Jahresstart 2025 in robuster Verfassung. Der Biotechnologie-Konzern verzeichnete am 18. Januar einen Kursanstieg von…

2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows

Some investors believe you make money when you buy a stock, not when you sell it. The logic behind this…

Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows.

A $5,000 investment can go a long way, especially if youre loading up on fairly cheap stocks that may possess…

Amgen Inc. (AMGN) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript)

…

3 High-Yield Dividend Stocks to Buy in 2025

High-yield dividend stocks may not appeal to some investors. However, if youre among those investors looking for income, stocks that…

Amgen Aktie: Softwaremarkt bleibt herausfordernd

San Francisco (www.aktiencheck.de) - Adobe-Aktienanalyse von Wells Fargo Advisors: Rating und Kursziel Wells Fargo hat das Kursziel für Amgen Inc. (ISIN: US0311621009,…

Amgen Aktie: Solide Q4-Ergebnisse erwartet - Neues Kursziel

Toronto (www.aktiencheck.de) - Amgen-Aktienanalyse von RBC Capital Markets: Rating und Kursziel RBC Capital hat das Kursziel für Amgen Inc. (ISIN: US0311621009, WKN:…

Amgen Aktie: Kursziel gesenkt - Hoher Wettbewerb dämpft Wachstumsperspektiven

Charlotte, NC (www.aktiencheck.de) - Amgen-Aktienanalyse von Truist: Rating und Kursziel Truist hat das Kursziel für Amgen Inc. (ISIN: US0311621009, WKN: 867900, Ticker-Symbol:…

The Zacks Analyst Blog Highlights Microsoft, Exxon Mobil, Amgen, PrimeEnergy Resources and FONAR

Microsoft, Exxon Mobil, Amgen, PrimeEnergy Resources and FONAR are part of the Zacks top Analyst Blog.…

Amgen: Blockbusters, Emerging Therapies, And Investment Potential

…

Top Analyst Reports for Microsoft, Exxon Mobil & Amgen

Todays Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Exxon Mobil Corporation (XOM) and…

Prediction: These 3 Healthcare Stocks Will Soar in 2025

No one knows for sure what the new year will hold for the market. However, some stocks chances for success…

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

The Dow Jones Industrial Average contains 30 handpicked companies that are, or at least once were, leaders in their respective…

Neue 7,75% Aktienanleihe mit Barriere Quanto auf Amgen in Zeichnung

München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VG016W8/ WKN VG016W)…

1 Beaten-Down Stock That Could Soar by 50% in 2025, According to Wall Street

Biotech giant Regeneron Pharmaceuticals (NASDAQ: REGN) started 2024 on a strong note and performed well through the first half of…

Amgen Aktie: Herausforderungen durch Verlust von Exklusivitäten

Minneapolis (www.aktiencheck.de) - Amgen-Aktienanalyse von Piper Sandler: Aktuelle Bewertung Piper Sandler hat das Kursziel für die Aktie von Amgen Inc. (ISIN: US0311621009,…

2 Excellent Dividend Stocks to Buy on the Dip

AbbVie (NYSE: ABBV) and Amgen (NASDAQ: AMGN) have a lot in common. They are both leading drugmakers and have strong…

Now That Nvidia and Amazon Are in the Dow Jones, Can the Index Beat the S&P 500 and Nasdaq in 2025?

The historic Dow Jones Industrial Average (DJINDICES: ^DJI) has undergone major changes in recent years. In 2020, Salesforce (NYSE: CRM),…

These Are the 5 Worst-Performing Stocks in the Dow Jones Industrial Average With 2024 Almost Over

Its been a banner year for the stock market. However, not every stock has been a winner as some sectors…

Amgen Aktie: BofA nimmt Coverage wieder auf - Herausforderungen durch Patentausläufe

Charlotte (www.aktiencheck.de) - Amgen-Aktienanalyse von BofA Securities: Rating und Kursziel BofA-Analyst Tim Anderson hat die Coverage der Aktie von Amgen Inc. (ISIN:…

Is Coca-Cola Stock a Buy, Sell, or Hold in 2025?

Coca-Cola (NYSE: KO) will likely be selling many more beverages in a few years than it did in 2024. Theres…

2 No-Brainer Dividend Stocks With Yields Over 3% to Buy in 2025 and Hold for a Decade or Longer

Whether youre looking for a way to beat the benchmark S&P 500 index or you just want a steady flow…